Intensive insulin therapy in the ICU—reconciling the evidence (Q57245227)

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Glucose normalization and outcomes in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Executive summary: standards of medical care in diabetes--2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

ESPEN Guidelines on Enteral Nutrition: Intensive care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

ESPEN Guidelines on Parenteral Nutrition: Intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units: Benefit Versus Harm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Survival Benefits of Intensive Insulin Therapy in Critical Illness: Impact of Maintaining Normoglycemia Versus Glycemia-Independent Actions of Insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Intensive insulin therapy in the medical ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Tight blood glucose control is renoprotective in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Achieving tight glycemic control in the operating room: lessons learned from 12 years in the trenches of a paradigm shift in anesthetic care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Effect of an intensive glucose management protocol on the mortality of critically ill adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Tight glucose control in the intensive care unit: are glucose meters up to the task?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Blood glucose measurements in arterial blood of intensive care unit patients submitted to tight glycemic control: agreement between bedside tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Glycemic control in the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests meeting clinical needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Glucose meter performance criteria for tight glycemic control estimated by simulation modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Reliability of point-of-care testing for glucose measurement in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Frequency of under- and overfeeding in mechanically ventilated ICU patients: causes and possible consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Combination enteral and parenteral nutrition in critically ill patients: harmful or beneficial? A systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Early versus Late Parenteral Nutrition in Critically Ill Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Intensive insulin therapy protects the endothelium of critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Insulin therapy protects the central and peripheral nervous system of intensive care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Hyperglycemic kidney damage in an animal model of prolonged critical illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

How does blood glucose control with insulin save lives in intensive care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Effect of Intensive Insulin Therapy on Insulin Sensitivity in the Critically Ill

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

21 January 2018

Autophagy and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Autophagy in the Pathogenesis of Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14

Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.14